Holdings of PROFUND VP PHARMACEUTICALS
ProFunds · Original filing · Compare with another fund · Report an error
- Net assets
- 11.5M $ including 11.2M $ in equities, 96.9 %
- Positions
- 65 in 3 countries
- Top ten
- 21.5 % of net assets
- Filed on
- Jun 30, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Definium Therapeutics Inc | 7,334 | 345K $ | 2.99 % |
| 2 | MBX BIOSCIENCES INC | 5,500 | 303.6K $ | 2.64 % |
| 3 | ALUMIS INC | 8,497 | 239.1K $ | 2.08 % |
| 4 | AtaiBeckley Inc | 45,092 | 237.6K $ | 2.06 % |
| 5 | Trevi Therapeutics Inc | 12,720 | 237.2K $ | 2.06 % |
| 6 | Enliven Therapeutics Inc | 4,607 | 233.8K $ | 2.03 % |
| 7 | AMYLYX PHARMACEUTICALS INC | 12,663 | 227.4K $ | 1.97 % |
| 8 | VERADERMICS INC | 1,833 | 225.3K $ | 1.96 % |
| 9 | Ligand Pharmaceuticals Inc | 687 | 217.2K $ | 1.89 % |
| 10 | Nuvation Bio Inc | 37,216 | 211.4K $ | 1.84 % |
| 11 | Edgewise Therapeutics Inc | 5,178 | 210.4K $ | 1.83 % |
| 12 | Nektar Therapeutics | 3,002 | 209.6K $ | 1.82 % |
| 13 | Liquidia Corp | 2,612 | 208.3K $ | 1.81 % |
| 14 | Maze Therapeutics Inc | 6,930 | 206.8K $ | 1.80 % |
| 15 | Harrow Inc | 4,748 | 201.6K $ | 1.75 % |
| 16 | EyePoint Inc | 13,824 | 197.7K $ | 1.72 % |
| 17 | Amneal Pharmaceuticals Inc | 11,126 | 192.6K $ | 1.67 % |
| 18 | OCULAR THERAPEUTIX INC | 19,502 | 191.5K $ | 1.66 % |
| 19 | Corcept Therapeutics Inc | 2,182 | 189.7K $ | 1.65 % |
| 20 | Crinetics Pharmaceuticals Inc | 4,965 | 185.8K $ | 1.61 % |
| 21 | Pacira BioSciences Inc | 7,278 | 184.6K $ | 1.60 % |
| 22 | Merck & Co Inc | 1,431 | 183.9K $ | 1.60 % |
| 23 | Indivior Pharmaceuticals Inc | 4,475 | 183.6K $ | 1.59 % |
| 24 | ELANCO ANIMAL HEALTH INC | 7,453 | 183.4K $ | 1.59 % |
| 25 | Johnson & Johnson | 715 | 181.6K $ | 1.58 % |
| 26 | Eli Lilly & Co | 150 | 179.9K $ | 1.56 % |
| 27 | JAZZ PHARMACEUTICALS PLC | 742 | 178.8K $ | 1.55 % |
| 28 | Collegium Pharmaceutical Inc | 4,898 | 177.3K $ | 1.54 % |
| 29 | Bristol-Myers Squibb Co | 3,066 | 176.7K $ | 1.53 % |
| 30 | Supernus Pharmaceuticals Inc | 3,780 | 175.8K $ | 1.53 % |
| 31 | ROYALTY PHARMA PLC | 3,127 | 175.3K $ | 1.52 % |
| 32 | TARSUS PHARMACEUTICALS INC | 2,782 | 175.1K $ | 1.52 % |
| 33 | WAVE LIFE SCIENCES LTD | 30,115 | 175K $ | 1.52 % |
| 34 | Harmony Biosciences Holdings Inc | 4,804 | 174.9K $ | 1.52 % |
| 35 | ANI Pharmaceuticals Inc | 2,084 | 172.5K $ | 1.50 % |
| 36 | Organon & Co | 12,739 | 172.5K $ | 1.50 % |
| 37 | VIATRIS INC | 10,808 | 171.6K $ | 1.49 % |
| 38 | Esperion Therapeutics Inc | 54,283 | 171.5K $ | 1.49 % |
| 39 | Axsome Therapeutics Inc | 692 | 169.4K $ | 1.47 % |
| 40 | Innoviva Inc | 7,411 | 168.3K $ | 1.46 % |
| 41 | BioAge Labs Inc | 6,835 | 167.5K $ | 1.45 % |
| 42 | Prestige Consumer Healthcare Inc | 3,469 | 164K $ | 1.42 % |
| 43 | Rapport Therapeutics Inc | 3,855 | 160.6K $ | 1.39 % |
| 44 | Pfizer Inc | 6,658 | 160.3K $ | 1.39 % |
| 45 | OMEROS CORP | 16,711 | 158.9K $ | 1.38 % |
| 46 | Perrigo Co PLC | 15,260 | 158.6K $ | 1.38 % |
| 47 | Xeris Biopharma Holdings Inc | 19,640 | 155.5K $ | 1.35 % |
| 48 | Zoetis Inc | 2,097 | 150.7K $ | 1.31 % |
| 49 | Eton Pharmaceuticals Inc | 4,026 | 145.7K $ | 1.27 % |
| 50 | Phibro Animal Health Corp | 4,568 | 143.4K $ | 1.25 % |
| 51 | Amphastar Pharmaceuticals Inc | 6,925 | 139.7K $ | 1.21 % |
| 52 | Arvinas Inc | 16,762 | 139.3K $ | 1.21 % |
| 53 | Zevra Therapeutics Inc | 9,630 | 138.1K $ | 1.20 % |
| 54 | Alto Neuroscience Inc | 4,959 | 130.9K $ | 1.14 % |
| 55 | Phathom Pharmaceuticals Inc | 10,944 | 118.7K $ | 1.03 % |
| 56 | Relmada Therapeutics Inc | 17,078 | 118.2K $ | 1.03 % |
| 57 | CorMedix Inc | 14,334 | 112.5K $ | 0.98 % |
| 58 | Septerna Inc | 3,303 | 110.6K $ | 0.96 % |
| 59 | Theravance Biopharma Inc | 6,286 | 106.9K $ | 0.93 % |
| 60 | Aclaris Therapeutics Inc | 18,874 | 99.8K $ | 0.87 % |
| 61 | LB Pharmaceuticals Inc | 2,742 | 89K $ | 0.77 % |
| 62 | Aquestive Therapeutics Inc | 20,535 | 85.4K $ | 0.74 % |
| 63 | FULCRUM THERAPEUTICS INC | 21,055 | 77.1K $ | 0.67 % |
| 64 | LEXICON PHARMACEUTICALS INC | 29,252 | 70.2K $ | 0.61 % |
| 65 | Evolus Inc | 8,464 | 58.7K $ | 0.51 % |
Sector breakdown
- Health care 12.4 %
- Unattributed 87.6 %
Titelia assigns each company to a sector, one by one. The unassigned share stays visible, under "Unattributed".
Currency breakdown
- USD 100.0 %
Each line is counted in its quoted currency, as the fund declares it.
Country breakdown
- United States 95.4 %
- Ireland 3.0 %
- Singapore 1.6 %
Shares are computed on the fund's equities only.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 62 | 10.7M $ | 95.41 % |
| 2 | Ireland | 2 | 337.4K $ | 3.02 % |
| 3 | Singapore | 1 | 175K $ | 1.57 % |
Cite this page
Titelia. "Holdings of PROFUND VP PHARMACEUTICALS". https://titelia.com/en/funds/S000003975